Modulation of aflatoxin metabolism, aflatoxin-n 7 -guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione s-transferases1

Cancer Research

Volumn 46, Issue 8, 1986, Pages 3924-3931

  Kenslei, Thomas W ^a   Egner, Patricia A ^a   Davidson, Nancy E ^b   Roebuck, B D ^c   Pikul, Anthony ^d   Groopman, John D ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ETHOXYQUIN; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; CANCER INHIBITION; CARCINOGENESIS; DIET; DNA ADDUCT; LIVER; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY;

AFLATOXIN B1; AFLATOXINS; ANIMALS; BILE; BUTYLATED HYDROXYANISOLE; BUTYLATED HYDROXYTOLUENE; DNA; ENZYME INDUCTION; ETHOXYQUIN; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GUANINE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; QUINOLINES; RATS; RATS, INBRED F344;

EID: 0022497046     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Busby, W. F., Jr., and Wogan, G. N. Aflatoxins. In: C. E. Searle (ed.), Chemical Carcinogens, Ed. 2, pp. 945-1136. Washington, DC: American Chemical Society, 1984
2. Stoloff. L. Occurrence of mycotoxins in food and feeds. In: J. V. Rodricks (ed.). Mycotoxins and Other Fungal Related Food Problems, pp. 23-50. Washington, DC: American Chemical Society, 1976.
3. Neal, G. E., and Green, J. A. The requirement for glutathione 5-transferase in the conjugation of activated aflatoxin B, during aflatoxin hepatocarcinogenesis in the rat. Chem.-Biol. Interact., 45:259-275
4. Degan, G. H., and Neumann, H. G. The major metabolite of aflatoxin Bi in the rat is a glutathione conjugate. Chem.-Biol. Interact., 22:239-255, 1981.
5. Neal, G. E., Judah, D. J., Stirpe, F., and Patterson, D. S. P. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B, by the metabolism of aflatoxin B| by liver microsomes isolated from certain avian and mammalian species and the possible role of the metabolite in the acute toxicity of aflatoxin B. Toxicity Appl. Pharmacol., 58:431-437, 1981.
6. Garner, R. C., and Wright, C. M. Induction of mutation in DNA-repair deficient bacteria by a liver microsomal metabolite of aflatoxin B. Br. J. Cancer, 28: 544-551, 1973.
7. Coles, B. F., Welch, A. M., Hertzog, P. J., Lindsay Smith, J. R., and Garner, R. C. Biological and chemical studies on 8,9-dihydroxy-8,9-dihydro-aflatoxin B and some of its esters. Carcinogenesis (Lond.), 1:74-80, 1980.
8. McLean, A. E. M., and Marshall, A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br. J. Exp. Pathol., 52:322-329, 1971.
9. Gurtoo, H. L., Koser, P. L., Bansal, S. K., Fox, H. W., Sharma, S. D., Mulhem, A. I., and Pavelic, Z. P. Inhibition of aflatoxin B,-hepatocarcinogenesis in rats by 0-naphthoflavone. Carcinogenesis (Lond.), 6: 675-678, 1985.
10. Wong, J. J., and Hsieh, D. P. H. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential. Proc. Natl. Acad. Sci. USA, 73: 2241-2244, 1976.
11. Gurtoo, H. L., Dahms, R. P., and Paigen, B. Metabolic activation of aflatox­ins related to their mutagenicity. Biochem. Biophys. Res. Commun., 61: 735-742, 1975.
12. Cabral, J. R. P., and Neal, G. E. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin Bj in rats. Cancer Lett., 19: 125-132, 1983.
13. Tanaka, T., Maeura, Y., Weisburger, J. H., and Williams, G. M. Inhibition of aflatoxin Bt (AFB,)-induced hepatocarcinogenesis by butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA). Proc. Amer. Assoc. Cancer Res. 26: 119, 1985.
14. Kozumbo, W. J., Trush, M. A., and Kensler, T. W. Are free radicals involved in tumor promotion? Chem.-Biol. Interact., 54: 199-207, 1985.
15. DeLong, M. J., Prochaska, H. J., and Talalay, P. Substituted phenols as inducers of enzymes that inactivate electrophilic compounds. In: D. C. McBrien, and T. F. Slater (eds.), Protective Agents in Human and Experi­mental Cancer, pp. 175-196. London: Academic Press, 1983.
16. Bieri, J. G. Second report of the ad hoc committee on standards for nutritional studies. J. Nutr., 110:1726, 1980.
17. Roebuck, B. D., Yager, J. D., and Longnecker, D. S. Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat. Cancer Res., 41:888­893, 1981.
18. Habig, W. H., Pabst, M. J., and Jakoby, W. B. Glutathione 5-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 219: 7130-7139, 1974.
19. Guenthner, T. M., Bentley, P., and Oesch, F. Microsomal epoxide hydrolase. Methods Enzymol., 77; 344-349, 1981.
20. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tolberg, N. E. A modifi­cation of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem., 87:206-210, 1978.
21. Kitahara, A., Satoh, K., and Sato, K. Properties of the increased glutathione 5-transferase A form in rat preneoplastic hepatic lesions induced by chemical carcinogens. Biochem. Biophys. Res. Commun., 112:20-28, 1983.
22. Chirgwin, J. M., Przybyla, A. E., MacDonald, J. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
23. Kafatos, F. C., Jones, W. C., and Efstratiadis, A. Determination of nucleic acid sequence homologies and relative concentrations by a dot blot hybridi­zation procedure. Nucleic Acids Res., 7: 1541-1552, 1979.
24. Rigby, P. W. J., Dickmann, M. Rhoades, C., and Berg, P. Labeling deoxy­ribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol., IS: 237-251, 1977.
25. Pickett, C. B., Telakowski-Hopkins, C. A., Ding, G. J.-F., Argenbright, L., and Lu, A. Y. H. Rat liver glutathione 5-transferases. Complete nucleotide sequence of a glutathione 5-transferase mRNA and the regulation of the Ya, Yb, and Yc mRNAs by 3-methyIcholanthrene and phenobarbital. J. Biol. Chem., 259:5182-5188, 1984.
26. Telakowski-Hopkins, C. A., Rodkey, J. A., Bennett, C. D., Lu, A. Y. H., and Pickett, C. B. Rat liver glutathione 5-transferases. Construction of a cDNA clone complementary to a Yc mRNA and prediction of the complete amino acid sequence of a Yc subunit. J. Biol. Chem., 260: 5820-5825, 1985.
27. Ding, G. J-F., Lu, A. Y. H., and Pickett, C. B. Rat liver glutathione 5- transferases: nucleotide sequence analysis of a Yb, cDNA clone and predic­tion of the complete amino acid sequence of the Ybt subunit. J. Biol. Chem., 260: 13268-13271, 1985.
28. Hymer, W. C., and Kruff, E. L. Isolation of nuclei from mammalian tissues through the use of Triton-X-100. J. Histochem. Cytochem., 12: 359-363, 1964.
29. Groopman, J. D., Busby, W. F., Jr., and Wogan, G. N. Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. Cancer Res., 40:4343-4351, 1980.
30. Lin, J., Miller, J. A., and Miller, E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxyaflatoxin B, a major acid hydrolysis product of aflatoxin B,-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res., 37:4430-4438, 1977.
31. Groopman, J. D., Croy, R. G., and Wogan, G. N. In vitro reactions of aflatoxin Bt-adducted DNA. Proc. Natl. Acad. Sci. USA, 78: 5445-5449, 1981.
32. Yager, J. D., Jr., and Yager, R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res., 40:3680­3685, 1980.
33. Roebuck, B. D. Enhancement of pancreatic carcinogenesis by raw soy protein isolate: quantitative rat model and nutritional considerations. In: M. Fried­man (ed.), Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods. Boston: Plenum, in press, 1986.
34. Pugh, T. D., King, J. H., Koen, H., Nychka, D., Chover, J., Wahba, G., He, Y., and Goldfarb, S. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res., 43: 1261-1268, 1983.
35. Snedecor, G. W., and Cocharn, W. G. Statistical Methods, pp. 273-275. Ames: Iowa State University Press, 1967.
36. Kensler, T. W., Egner, P. A., Trush, M. A., Bueding, E., and Groopman, J. D. Modification of aflatoxin Bi binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis (Lond.), 6:759­763, 1985.
37. Croy, R. G., and Wogan, G. N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B,. Cancer Res., 41: 197-203, 1981.
38. Wogan, G. N. Aflatoxin carcinogenesis. Methods Cancer Res., 8: 309-344, 1973.
39. Appleton, B. S., and Campbell, T. C. Effect of high and low dietary protein on the dosing and postdosing periods of aflatoxin Brinduced hepatic preneo­plastic lesion development in the rat. Cancer Res., 43:2150-2154, 1983.
40. Benson, A. M., Batzinger, R. P., Ou, S-Y. L., Bueding, E., Cha, Y-N., and Talalay, P. Elevation of hepatic glutathione 5-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary an­tioxidants. Cancer Res., 38:4486-4495,1978.
41. Pearson, W. R., Windle, J. J., Morrow, J. F., Benson, A. M., and Talalay, P. Increased synthesis of glutathione 5-transferase in response to anticarcinogenic antioxidants. Cloning and measurement of messenger RNA. J. Biol. Chem., 258:2052-2062, 1983.
42. Benson, A. M., Hunkeler, M. J., and Morrow, J. F. Kinetics of glutathione transferase, glutathione transferase messenger RNA, and reduced nicotina­mide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)- ferf-butyl-4-hydroxyanisole in mice. Cancer Res., 44:5256-5261, 1984.
43. Coles, B., Meyer, D. J., Ketterer, B., Stanton, C. A., and Garner, R. C. Studies on the detoxication of microsomally-activated aflatoxin Bi by gluta­thione and glutathione transferases in vitro. Carcinogenesis (Lond.), 6:693­697, 1985.
44. Salocks, C. B., Hsieh, D. P. H., and Byard, J. L. Effects of butylated hydroxytoluene pretreatment on the metabolism and genotoxicity of afla­toxin Bi in primary cultures of adult rat hepatocytes: selective reduction of nucleic acid binding. Toxicol. Appl. Pharmacol., 76:498-509, 1984.
45. Lotlikar, P. D., Clearfield, M. S., and Jhee, E. C. Effect of butylated hydroxyanisole on in vivo and in vitro hepatic aflatoxin Bj-DNA binding in rats. Cancer Lett., 24:241-250,1984.
46. Lotlikar, P. D., Jhee, E. C., Insetta, S. M., and Clearfield, M. S. Modulation of microsome-mediated aflatoxin Bi binding to exogenous and endogenous DNA by cytosolic glutathione 5-transferase in rat and hamster. Carcinogen­esis (Lond.), 5; 269-276, 1984.
47. Croy, R. G., and Wogan, G. N. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys. J. Natl. Cancer Inst., 66: 761-768, 1981.
48. Wogan, G. N., Croy, R. G., Essigmann, J. M., Groopman, J. D., Thilly, W. G., Skopek, T. R., and Lieber, H. L. Mechanisms of action of aflatoxin Bi and sterigmatocystin: relationships of macromolecular binding to carcino­genicity and mutagenicity. In: P. Emmelot and E. Kriek (ed.), Environmental Carcinogenesis, pp. 97-121. Amsterdam: Elsevier/North Holland, 1979.
49. Shapiro, R. Chemistry of guanine and its biologically significant derivatives. Prog. Nucleic Acids Res. Mol. Biol., 8:73-112, 1968.
50. Foster, P. L., Eisenstadt, E., and Miller, J. H. Base substitution mutations induced by metabolically activated aflatoxin Bi. Proc. Natl. Acad. Sci. USA, 80:2695-2698, 1983.
51. Beland, F. A.,.Dooley, K. L., and Jackson, C. D. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2- acetylaminofluorene. Cancer Res., 42: 1348-1354,1982.
52. Cox, R., and Irving, C. C. 0-Methylguanine accumulates in DNA of mam­mary glands after administration of jV-methyl-N-nitrosourea to rats. Cancer Lett., 6: 273-278, 1979.
53. Goth, R., and Rajewsky, M. F. Persistence of 06-ethylguanine in rat brain DNA: correlation with nervous-system specific carcinogenesis by ethylnitrosourea. Proc. Natl. Acad. Sci. USA, 71:639-643, 1974.
54. Pegg, A. E., and Perry, W. Alkylation of nucleic acids and metabolism of small doses of dimethylnitrosamine in the rat. Cancer Res., 41: 3128-3132, 1981.
55. DiGiovanni, J., Decina, P. C., Pritchett, W. P., Fisher, E. P., and Aalfs, K. K. Formation and disappearance of benzo(a)pyrene DNA-adducts in mouse epidermis. Carcinogenesis (Lond.), 6: 741-747, 1985.
56. Randerrath, K., Agrawal, H., and Randerath, E. 12-0-Tetradecanoylphorbol- 13-acetate-induced rapid loss of persistent 7,12-dimethylbenz[a]anthracene- DNA adducts in mouse epidermis and dermis. Cancer Lett., 27:35-43,1985.
57. Farber, E. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. Cancer Res., 44: 5463-5474, 1984.
58. Bernstein, L., Gold, L. S., Ames, B. N., Pike, M., and Hoel, D. G. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fund. Appl. Toxicol., 5: 79-86, 1985.
59. Wogan, G. N., and Gorelick, N. J. Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ. Health Perspect. 62: 5-18, 1985.
60. Groopman, J. D., Trudel, L. J., Donahue, P. R., Marshak-Rothstein, A., and Wogan, G. N. High-affinity antibodies for aflatoxins and their application to solid-phase immunoassays. Proc. Natl. Acad. Sci. USA, 81: 7728-7731, 1984.
61. Groopman, J. D., Donahue, P. R., Zhu, J., Chen, J., and Wogan, G. N. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA, 82: 6492-6496, 1985.
62. Williams, G. M., Macura, Y., and Weisburger, J. H. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2- fluorenylacetamide by butylated hydroxytoluene. Cancer Lett., 19: 55-60, 1983.
63. Imaida, K., Fukushima, S., Shirai, T., Mausi, T., Ogiso, T., and Ito, N. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene, and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Gann, 75: 769-775, 1984.
64. Ito, N., Fukushima, S., Hagiwara, A., Shibata, M., and Ogiso, T. Carcino­genicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst., 70: 343-352, 1983.
65. Fukushima, S., Kurata, Y., Shibata, M., Ikawa, E., and Ito, N. Promotion by ascorbic acid, sodium erythorbate, and ethoxyquin of neoplastic lesions in rats initiated with Ar-butyl-Ar-<4-hydroxybutyl)nitrosamine. Cancer Lett., 23: 29-37, 1984.